Alerts

Patients may be injured if they wear face masks (such as surgical or non-surgical masks and respirators) with metal parts and coatings during an MRI examination

Safety investigation in response to concerns that increased antidepressant prescribing had resulted in an increased rate of suicide in young people in Australia

Low levels of contamination with N-nitrosodimethylamine (NDMA)

Grain German Shepherd tablets pose a serious risk to your health and should not be taken.

Rise 2.0 Liquid Cialis 30ml bottles pose a serious risk to your health and should not be taken.

INFINITY 10K capsules pose a serious risk to your health and should not be taken

Update - Suspended breast implant devices now cancelled

KANGAROO 2019 Mega 3000 tablets pose a serious risk to your health and should not be taken

H.R.D. Tablets pose a serious risk to your health and should not be taken

BEAST Natural Formula 41,000 MG capsules pose a serious risk to your health and should not be taken

Update 2 - contamination with N-nitrosodimethylamine

SCORPION Natural Formula 41,000 MG capsules pose a serious risk to your health and should not be taken

Safety advisory - potential risk during pregnancy

List of alerts on potential issues when used for uterine surgery in patients with fibroids

Safety advisory - potential for liver injury

YongGang tablets pose a serious risk to your health and should not be taken.

Maxman XI tablets pose a serious risk to your health and should not be taken

Safety advisory - contains dangerous levels of lead and other heavy metals

Safety advisory - risk of serious skin reactions

Update - PBS changes and supplier letter reinforce prescribing guidance

Safety advisory - increased risk of non-melanoma skin cancer

A new large-scale study has affirmed the safety of quadrivalent human papillomavirus vaccine for both boys and girls

AuLion Energy Candy poses a serious risk to your health and should not be taken

V-MAX herbal tablets pose a serious risk to your health and should not be taken

Update on FDA post-approval study